[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant.
Article in Clinical Cancer Research (February 2023)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Classifying Breast Cancer Metastasis Based on Imaging of Tumor Primary and Tumor Biology
Article in Diagnostics (January 2023)
Molecular imaging as biomarker for treatment response and outcome in breast cancer
Article in Therapeutic Advances in Medical Oncology (January 2023)